Market News
Stay updated with the latest market trends, earnings, and economic indicators.
M-Cap of Vedanta's split cos jumps 67% to Rs 3.5 lakh crore
Vedanta's demerger has boosted shareholder value. The combined market capitalization of the parent and four new entities surged significantly. Investors are showing a premium for pure-play exposure to sectors like aluminium and oil and gas. Vedanta Aluminium is the dominant value driver. The residual Vedanta entity also holds substantial valuation. Smaller verticals are yet to see a rerating.
Japan company to set up rare earths magnet unit in Andhra Pradesh
Japan's Proterial will invest ₹2,250 crore to build a rare earth magnet plant in Andhra Pradesh. This facility will produce vital components for electric vehicles and wind turbines. The move aims to boost India's local rare earth value chain. It also reduces dependence on Chinese sources. This strategic investment strengthens India's manufacturing capabilities in key sectors.
Why top fund managers think foreign investors could return to India
India's market outlook is improving as oil prices ease and geopolitical risks recede. Sunil Singhania, Founder of Abakkus Asset Manager, Prashant Khemka, Founder, Whiteoak Capital and Nilesh Shah, Managing Director at Kotak Mahindra AMC explain why foreign investor sentiment could improve, where earnings growth is strongest, and which sectors—from banks to renewables—offer the most compelling opportunities.
Tata Motors among 4 stocks showing bullish RSI upswing
Four Nifty 500 stocks that gained more than 8% were identified through StockEdge.com's RSI Trending Up scan on June 12. The stocks showed RSI values crossing above 50 from lower levels, indicating strengthening momentum. The list includes Tata Motors, Tata Teleservices (Maharashtra), Netweb Technologies India and Authum Investment & Infrastructure.
Vedanta demerger: Listing date, 4 new names, special trading session. 8 things shareholders should know
Vedanta's landmark demerger is set to unlock value for shareholders, with four newly created entities scheduled for listing and trading on June 15 through a special pre-open session.
Tata Motors PV To Hike Car And SUV Prices From July 1 — Check Details
The company said the adjustment is aimed at partially offsetting cost pressures while maintaining the overall value proposition of each offering.
A Bosch 'bear' turns bullish, raises target by 63% to highest on the Street
UBS said a recent repositioning of Bosch's portfolio has improved the investment case for the company. According to the brokerage, the acquisition of the Chassis Systems business enhances the stock's value creation potential, while recently announced joint ventures could provide additional upside.
Wipro buyback is live! Experts reveal the catch behind the 37% premium - Everything shareholders need to know
Wipro's ₹15,000 crore share buyback, priced at ₹250 per share, offers 37% premium over market value. The buyback, open until June 17, allows eligible shareholders to tender shares, with specific entitlement ratios for retail and general investors.
Nifty 500 Q4 Review: HDFC Bank, Indian Oil, Tata Motors Among Top Winners, Losers; Key Sector Trend — Read Motilal Oswal's Report
Of the 23 key sectors, 14 posted double-digit profit growth in Q4 FY26.
Wipro's Rs 15,000 crore buyback opens tomorrow: 10 key things to know before tendering shares
Wipro's substantial Rs 15,000 crore share buyback commences tomorrow, June 11, closing on June 17. Investors can tender shares at Rs 250 each, offering a significant premium. Small shareholders receive preferential treatment with a dedicated quota. This move aims to boost share value and utilize surplus cash, with promoters also participating.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.